The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Silvio Danese

IBD Center

Gastroenterology

Humanitas Clinical and Research Center

Milan

Italy. Electronic address:

[email]@hotmail.com

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • IBD Center, Gastroenterology, Humanitas Clinical and Research Center, Milan, Italy. Electronic address:. 2012
  • IBD Center, Gastroenterology, IRCCS Humanitas, Rozzano, Italy. 2011
  • Division of Gastroenterology, Instituto Clinico Humanitas, IRCCS in Gastroenterology, Via Manzoni 56, Italy. 2006 - 2011
  • Inflammatory Bowel Disease Unit, Division of Gastroenterology, Milan, Italy. 2010
  • Department of Internal Medicine, Institute of General Pathology, Catholic University, Italy. 2005 - 2006
  • Department of Internal Medicine, Catholic University School of Medicine, L.go Vito 1, 00168 Rome, Italy. 2005

References

  1. Regulatory T-cell therapy for Crohn's disease: in vivo veritas. Danese, S., Fiorino, G., Rutella, S. Gastroenterology (2012) [Pubmed]
  2. Biological Therapy for Ulcerative Colitis: what is after Anti-TNF. Fiorino, G., Cesarini, M., Danese, S. Curr. Drug. Targets (2011) [Pubmed]
  3. Review article: infliximab for Crohn's disease treatment--shifting therapeutic strategies after 10 years of clinical experience. Danese, S., Colombel, J.F., Reinisch, W., Rutgeerts, P.J. Aliment. Pharmacol. Ther. (2011) [Pubmed]
  4. IBD: of mice and men-shedding new light on IL-13 activity in IBD. Danese, S. Nat. Rev. Gastroenterol. Hepatol (2011) [Pubmed]
  5. Narrow-band imaging endoscopy to assess mucosal angiogenesis in inflammatory bowel disease: a pilot study. Danese, S., Fiorino, G., Angelucci, E., Vetrano, S., Pagano, N., Rando, G., Spinelli, A., Malesci, A., Repici, A. World J. Gastroenterol. (2010) [Pubmed]
  6. Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin-Yang interplay between inflammation and cancer. Danese, S., Mantovani, A. Oncogene (2010) [Pubmed]
  7. The protein C pathway in tissue inflammation and injury: pathogenic role and therapeutic implications. Danese, S., Vetrano, S., Zhang, L., Poplis, V.A., Castellino, F.J. Blood (2010) [Pubmed]
  8. Interleukin-6: a therapeutic Jekyll and Hyde in gastrointestinal and hepatic diseases. Danese, S., Gao, B. Gut (2010) [Pubmed]
  9. Colorectal cancer screening: dying en route?. Danese, S., Laghi, L., Repici, A., Malesci, A. Dig. Liver. Dis (2010) [Pubmed]
  10. New and emerging biologics in the treatment of inflammatory bowel disease: quo vadis? Danese, S., Angelucci, E. Gastroenterol. Clin. Biol. (2009) [Pubmed]
  11. Emerging Biologics in the Treatment of Inflammatory Bowel Disease: What is Around the Corner?. Fiorino, G., Rovida, S., Correale, C., Danese, S. Curr. Drug. Targets (2009) [Pubmed]
  12. PAI-1 and TAFI in inflammatory bowel disease: the yin and yang of the fibrinolytic system. Danese, S., Papa, A. Eur. J. Gastroenterol. Hepatol (2008) [Pubmed]
  13. Oral beclomethasone: a review of its use in inflammatory bowel disease. Danese, S., Angelucci, E., Marconi, S., Repici, A., Malesci, A. Mini. Rev. Med. Chem (2008) [Pubmed]
  14. Mechanisms of action of infliximab in inflammatory bowel disease: an anti-inflammatory multitasker. Danese, S. Dig. Liver. Dis (2008) [Pubmed]
  15. Biological agents for ulcerative colitis: hypes and hopes. Danese, S., Angelucci, E., Malesci, A., Caprilli, R. Med. Res. Rev (2008) [Pubmed]
  16. Negative regulators of angiogenesis in inflammatory bowel disease: thrombospondin in the spotlight. Danese, S. Pathobiology (2008) [Pubmed]
  17. Cytapheresis in inflammatory bowel diseases: current evidence and perspectives. Danese, S., Angelucci, E., Stefanelli, T., Omodei, P., Luigiano, C., Finazzi, S., Pagano, N., Repici, A., Vecchi, M., Malesci, A. Digestion (2008) [Pubmed]
  18. VEGF in inflammatory bowel disease: a master regulator of mucosal immune-driven angiogenesis. Danese, S. Dig. Liver. Dis (2008) [Pubmed]
  19. Nonimmune cells in inflammatory bowel disease: from victim to villain. Danese, S. Trends Immunol. (2008) [Pubmed]
  20. Angiogenesis blockade as a new therapeutic approach to experimental colitis. Danese, S., Sans, M., Spencer, D.M., Beck, I., Doñate, F., Plunkett, M.L., de la Motte, C., Redline, R., Shaw, D.E., Levine, A.D., Mazar, A.P., Fiocchi, C. Gut (2007) [Pubmed]
  21. Tumor necrosis factor-alpha monoclonal antibodies for Crohn's disease: tipping the balance. Danese, S., Pagano, N., Angelucci, E., Stefanelli, T., Repici, A., Omodei, P., Daperno, M., Malesci, A. Curr. Med. Chem. (2007) [Pubmed]
  22. Critical role of the CD40 CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease. Danese, S., Scaldaferri, F., Vetrano, S., Stefanelli, T., Graziani, C., Repici, A., Ricci, R., Straface, G., Sgambato, A., Malesci, A., Fiocchi, C., Rutella, S. Gut (2007) [Pubmed]
  23. Inflammation and the mucosal microcirculation in inflammatory bowel disease: the ebb and flow. Danese, S. Curr. Opin. Gastroenterol. (2007) [Pubmed]
  24. TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease. Danese, S., Sans, M., Scaldaferri, F., Sgambato, A., Rutella, S., Cittadini, A., Piqué, J.M., Panes, J., Katz, J.A., Gasbarrini, A., Fiocchi, C. J. Immunol. (2006) [Pubmed]
  25. Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. Danese, S., Sans, M., de la Motte, C., Graziani, C., West, G., Phillips, M.H., Pola, R., Rutella, S., Willis, J., Gasbarrini, A., Fiocchi, C. Gastroenterology (2006) [Pubmed]
  26. Biological therapies for inflammatory bowel disease: research drives clinics. Danese, S., Semeraro, S., Armuzzi, A., Papa, A., Gasbarrini, A. Mini. Rev. Med. Chem (2006) [Pubmed]
  27. Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease. Danese, S., Sgambato, A., Papa, A., Scaldaferri, F., Pola, R., Sans, M., Lovecchio, M., Gasbarrini, G., Cittadini, A., Gasbarrini, A. Am. J. Gastroenterol. (2005) [Pubmed]
  28. Platelet activation and the CD40/CD40 ligand pathway: mechanisms and implications for human disease. Danese, S., Fiocchi, C. Crit. Rev. Immunol. (2005) [Pubmed]
  29. Adhesion molecules in inflammatory bowel disease: therapeutic implications for gut inflammation. Danese, S., Semeraro, S., Marini, M., Roberto, I., Armuzzi, A., Papa, A., Gasbarrini, A. Dig. Liver. Dis (2005) [Pubmed]
  30. Chemokines in inflammatory bowel disease. Danese, S., Gasbarrini, A. J. Clin. Pathol. (2005) [Pubmed]
  31. Extraintestinal manifestations in inflammatory bowel disease. Danese, S., Semeraro, S., Papa, A., Roberto, I., Scaldaferri, F., Fedeli, G., Gasbarrini, G., Gasbarrini, A. World J. Gastroenterol. (2005) [Pubmed]
 
WikiGenes - Universities